TY - JOUR
T1 - Total synthesis of dehaloperophoramidine using a highly diastereoselective Hosomi-Sakurai reaction
AU - Wilkie, Ross Philip
AU - Neal, Andrew
AU - Johnston, Craig Andrew
AU - Voûte, Nicholas
AU - Lancefield, Christopher Stuart
AU - Stell, Matthew
AU - Medda, Federico
AU - Makiyi, Edward Frank
AU - Turner, Emma
AU - Ojo, Oluwarotimi Stephen
AU - Slawin, Alexandra Martha Zoya
AU - Lebl, Tomas
AU - Mullen, Peter
AU - Harrison, David James
AU - Ireland, Chris M
AU - Westwood, Nicholas James
N1 - The authors would like to acknowledge EPSRC for PhD funding through the Doctoral Training Schemes.
PY - 2016/9/14
Y1 - 2016/9/14
N2 - The synthesis of dehaloperophoramidine, a non-halogenated derivative of the marine natural product perophoramidine, is reported. The key steps included a [3,3]-Claisen rearrangement and an epoxide opening/allylsilylation (modified Hosomi-Sakurai) reaction to install the contiguous all-carbon quaternary stereocentres with the required relative stereochemistry. The first five steps were carried out on seventy gram scale without the need for chromatography. Resolution of the [3,3]-Claisen product gave samples of the highly enantiomerically-enriched ketones which are flexible starting points for the synthesis of a number of complex ring structures. A regio- and diastereo-selective iodocyclisation was then used to differentiate between two allyl groups enabling the synthesis of the target molecule by two different routes. A detailed comparison of the trifluoroacetic acid salt of the synthetic dehaloperophoramidine with authentic material was carried out including a key doping experiment. Biological testing showed that (±)-dehaloperophoramidine was cytotoxic to HCT116, HT29 and LoVo colorectal carcinoma cells with comparable activity to that reported for the halogenated perophoramidine. This demonstrated for the first time that the halogens are not essential for the biological activity of this alkaloid class.
AB - The synthesis of dehaloperophoramidine, a non-halogenated derivative of the marine natural product perophoramidine, is reported. The key steps included a [3,3]-Claisen rearrangement and an epoxide opening/allylsilylation (modified Hosomi-Sakurai) reaction to install the contiguous all-carbon quaternary stereocentres with the required relative stereochemistry. The first five steps were carried out on seventy gram scale without the need for chromatography. Resolution of the [3,3]-Claisen product gave samples of the highly enantiomerically-enriched ketones which are flexible starting points for the synthesis of a number of complex ring structures. A regio- and diastereo-selective iodocyclisation was then used to differentiate between two allyl groups enabling the synthesis of the target molecule by two different routes. A detailed comparison of the trifluoroacetic acid salt of the synthetic dehaloperophoramidine with authentic material was carried out including a key doping experiment. Biological testing showed that (±)-dehaloperophoramidine was cytotoxic to HCT116, HT29 and LoVo colorectal carcinoma cells with comparable activity to that reported for the halogenated perophoramidine. This demonstrated for the first time that the halogens are not essential for the biological activity of this alkaloid class.
UR - http://www.rsc.org/suppdata/c6/cc/c6cc05747k/c6cc05747k1.pdf
U2 - 10.1039/c6cc05747k
DO - 10.1039/c6cc05747k
M3 - Article
SN - 1359-7345
VL - 52
SP - 10747
EP - 10750
JO - Chemical Communications
JF - Chemical Communications
IS - 71
ER -